1-7 of 7
Erika Lerch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Melphalan Dose in Myeloma Patients over 65 Years of Age Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Guido Ghilardi, MD, Thomas Pabst, MD, Barbara Jeker, MD, Rouven Müller, MD, Anne Cairoli, MD, Antonia Mueller, MD, Mario Bargetzi, MD, Felicitas Hitz, MD, Helen Baldomero, Dominik Heim, MD, Davide Rossi, MD PhD, Michele Ghielmini, MD, Erika Lerch, MD, Urs Schanz, MD, Jakob R. Passweg, MDMS, Georg Stussi, MD, Martina Kleber, MD, Bernhard Gerber
Journal: Blood
Blood (2017) 130 (Supplement 1): 3297.
https://doi.org/10.1182/blood.V130.Suppl_1.3297.3297
Published: 2017
Journal Articles

Plasma Cell Disease Genotyping with the Liquid Biopsy

Bernhard Gerber, Martina Manzoni, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Sonia Fabris, BSc, Marzia Barbieri, Gabriella Ciceri, Marta Lionetti, Alessandra Pompa, Gabriela Forestieri, Erika Lerch, MD, Paolo Servida, Francesco Bertoni, MD, Emanuele Zucca, MD, Michele Ghielmini, MD, Agostino Cortelezzi, Prof, Franco Cavalli, MD, Georg Stussi, MD, Luca Baldini, Davide Rossi, MD PhD, Antonino Neri
Journal: Blood
Blood (2017) 130 (Supplement 1): 327.
https://doi.org/10.1182/blood.V130.Suppl_1.327.327
Published: 2017
Journal Articles

Survival of Patients Autografted for Chemosensitive Hodgkin Lymphoma After Failure of Upfront BEACOPP Escalated Versus ABVD-Like Regimens

Luciano Wannesson, MD, Mario Bargetzi, MD, Anne Cairoli, MD, Dominik Heim, MD, Urs Hess, MD, Erika Lerch, MD, Thomas Pabst, MD, Christoph Renner, MD, Panagiotis Samaras, MD, Emanuele Zucca, MD
Journal: Blood
Blood (2011) 118 (21): 3098.
https://doi.org/10.1182/blood.V118.21.3098.3098
Published: 2011
Journal Articles

Pegfilgrastim Accelerates Neutrophil Engraftment, Reduces the Number of Neutropenic and Hospitalization Days and the Use of Antibiotics After Autologous Peripheral Blood Stem Cell Transplant for Multiple Myeloma and Lymphoma. A Phase II Study and Comparison with a Filgrastim Treated Historical Cohort.

Luciano Wannesson, François Luthi, Emanuele Zucca, Anne Rosselet, Mauro Baglioni, Erika Lerch, Kristin Feuerlein, Michele Ghielmini, Nicolas Ketterer
Journal: Blood
Blood (2009) 114 (22): 2274.
https://doi.org/10.1182/blood.V114.22.2274.2274
Published: 2009
Journal Articles

A Phase I–II Study To Determine the Maximum Tolerated Infusion-Rate of Rituximab, with a Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function.

Marco Siano, M.D., Erika Lerch, M.D., Emanuele Zucca, M.D., Oreste Mora, M.D., Cristiana Sessa, M.D., Michele Ghielmini, MD
Journal: Blood
Blood (2007) 110 (11): 3411.
https://doi.org/10.1182/blood.V110.11.3411.3411
Published: 2007
Journal Articles

Interim Results of a Phase I/II Study of Ocrelizumab, a New Humanised Anti-CD20 Antibody in Patients with Relapsed/Refractory Follicular Non-Hodgkin’s Lymphoma.

Franck Morschhauser, Paula Marlton, Umberto Vitolo, Ola Linden, John Seymour, Michael Crump, Bertrand Coiffier, Alessandro Pulsoni, Andrew Belch, Erika Lerch, Eva Kimby, Kristina Arnljots, Elisabeth Wassner, Myriam Mendila
Journal: Blood
Blood (2007) 110 (11): 645.
https://doi.org/10.1182/blood.V110.11.645.645
Published: 2007
Journal Articles

Infusion Speed-Escalation Trial To Give Full-Dose Rituximab in One Hour without Steroids Pre-Medication.

Michele Ghielmini, PD, MD, Laura Negretti, MD, Erika Lerch, MD, Barbara Roth, MD, Michèle Voegeli, MD, Tatiana Terrot, Flavia Pandiani, Emanuele Zucca, PD, MD, Cristiana Sessa, PD, MD
Journal: Blood
Blood (2005) 106 (11): 2451.
https://doi.org/10.1182/blood.V106.11.2451.2451
Published: 2005